Literature DB >> 6119967

Stimulated lymphocytes in schizophrenia.

M Hirata-Hibi, S Higashi, T Tachibana, N Watanabe.   

Abstract

This study examines the effect of neuroleptic medication on the distribution of the reported atypical lymphocytes of schizophrenia. The predominant atypical type in schizophrenia was termed the P-type atypical lymphocyte to differentiate the cell from other types of peripheral lymphocytes. Such P cells showed stimulated features: clear cytoplasmic basophilia and an irregularly shaped nucleus with a leptochromatic structure and occasionally one or two nucleoli, but the cell size ranged from small to large. P cells were found in all 42 schizophrenic patients examined and ranged from 5% to 45% of lymphocytes. Patients receiving neuroleptic medication had a lower mean percentage of P cells (17.8%) compared with patients not receiving neuroleptic medication (28.7%). The findings indicate that neuroleptic medication in not likely to be inducing the P-cell reaction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6119967     DOI: 10.1001/archpsyc.1982.04290010058011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  7 in total

1.  Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients.

Authors:  L E DeLisi; J R Ortaldo; A E Maluish; R J Wyatt
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 2.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  Cytotoxic anti-lymphocyte antibody in schizophrenics.

Authors:  M Kagami; T Koike; N Maruyama; K Takabayashi; H Tomioka; S Yoshida; Y Kon
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

4.  Elevated Le(y) antigen expression on T-lymphocytes in schizophrenic patients.

Authors:  M Kokai; I Hirata; M Adachi; N Hatotani; S Hakomori; T Tachibana
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 5.  Multiple Sclerosis and Schizophrenia.

Authors:  Borros M Arneth
Journal:  Int J Mol Sci       Date:  2017-08-12       Impact factor: 5.923

6.  1Q12 Loci Movement in the Interphase Nucleus Under the Action of ROS Is an Important Component of the Mechanism That Determines Copy Number Variation of Satellite III (1q12) in Health and Schizophrenia.

Authors:  Marina Sergeevna Konkova; Elizaveta Sergeevna Ershova; Ekaterina Alekseevna Savinova; Elena Mikhailovna Malinovskaya; Galina Vasilievna Shmarina; Andrey Vladimirovich Martynov; Roman Vladimirovich Veiko; Nataly Vyacheslavovna Zakharova; Pavel Umriukhin; Georgy Petrovich Kostyuk; Vera Leonidovna Izhevskaya; Sergey Ivanovich Kutsev; Natalia Nikolaevna Veiko; Svetlana Victorovna Kostyuk
Journal:  Front Cell Dev Biol       Date:  2020-06-05

7.  Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.

Authors:  Sonja Orlovska-Waast; Ole Köhler-Forsberg; Sophie Wiben Brix; Merete Nordentoft; Daniel Kondziella; Jesper Krogh; Michael Eriksen Benros
Journal:  Mol Psychiatry       Date:  2018-08-16       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.